Artículos por temáticas

Favorable long-term cognitive outcomes following recurrent ARIA linked to amyloid-lowering therapies: two cases

Zavarella M, Cecchetti G, Rugarli G, Ghirelli A, Bottale I, Orlandi F, Spinelli EG, Santangelo R, Caso F, Calloni SF, Vezzulli PQ, Falini A, Magnani G, Agosta F, Filippi M.

J Neurol. 2025 Jan 24;272(2):168. doi: 10.1007/s00415-025-12910-x.

Protocol for an intergenerational randomized controlled trial to enhance physical activity in older adults at risk for Alzheimer's disease

Walker CS, Noriega de la Colina AE, Li L, Boulanger C, Thovinakere N, Noly-Gandon A, Barnoin G, Bennett M, Caplan J, Côté L, Elbaz S, Bao SFK, Kara R, Lavoie N, Nguyen M, Otaner F, Pallett-Wiesel H, P

J Prev Alzheimers Dis. 2025 Mar;12(3):100039. doi: 10.1016/j.tjpad.2024.100039. Epub 2025 Jan 9.

Grey-Matter Structure Markers of Alzheimer's Disease, Alzheimer's Conversion, Functioning and Cognition: A Meta-Analysis Across 11 Cohorts

Couvy-Duchesne B, Frouin V, Bouteloup V, Koussis N, Sidorenko J, Jiang J, Wink AM, Lorenzini L, Barkhof F, Trollor JN, Mangin JF, Sachdev PS, Brodaty H, Lupton MK, Breakspear M, Colliot O, Visscher PM

Hum Brain Mapp. 2025 Feb 1;46(2):e70089. doi: 10.1002/hbm.70089.

Posterior Cortical Atrophy Due to Alzheimer Disease in a Person With Down Syndrome: A Case Report

Rodríguez-Baz Í, Benejam B, Morcillo-Nieto AO, Vaqué-Alcázar L, Arriola-Infante JE, Camacho V, Aranha MR, Carmona-Iragui M, Videla L, Barroeta I, Fernández S, Zsadanyi SE, Giménez S, Arranz J, Maure B

Neurology. 2025 Jan 14;104(1):e210179. doi: 10.1212/WNL.0000000000210179. Epub 2024 Dec 17.

Comparison of the amyloid plaque proteome in Down syndrome, early-onset Alzheimer's disease, and late-onset Alzheimer's disease

Martá-Ariza M, Leitner DF, Kanshin E, Suazo J, Giusti Pedrosa A, Thierry M, Lee EB, Devinsky O, Drummond E, Fortea J, Lleó A, Ueberheide B, Wisniewski T.

Acta Neuropathol. 2025 Jan 18;149(1):9. doi: 10.1007/s00401-025-02844-z.

Pre-treatment subjective sleep quality as a predictive biomarker of tDCS effects in preclinical Alzheimer's disease patients: Secondary analysis of a randomised clinical trial

Lu H, Ni X, Man Chan SS, Cheng CPW, Chan W, Lam LCW.

PLoS One. 2025 Jan 28;20(1):e0317700. doi: 10.1371/journal.pone.0317700. eCollection 2025.

Advancing Alzheimer's disease risk prediction: development and validation of a machine learning-based preclinical screening model in a cross-sectional study

Wang B, Xie R, Qi W, Yao J, Shi Y, Lou X, Dong C, Zhu X, Wang B, He D, Chen Y, Cao S.

BMJ Open. 2025 Feb 8;15(2):e092293. doi: 10.1136/bmjopen-2024-092293.

Association of Seizure Control with Mortality, Cognition, and Function in People With Dementia

Zawar I, Quigg M, Ghosal S, Punia V, Calle-Lopez Y, Manning C, Kapur J.

Ann Neurol. 2025 Feb;97(2):358-368. doi: 10.1002/ana.27125. Epub 2024 Oct 30.

The Alzheimer's Association clinical practice guideline for the diagnostic evaluation, testing, counseling, and disclosure of suspected Alzheimer's disease and related disorders (DETeCD-ADRD): Validated clinical assessment instruments

Atri A, Dickerson BC, Clevenger C, Karlawish J, Knopman D, Lin PJ, Norman M, Onyike C, Sano M, Scanland S, Carrillo M.

Alzheimers Dement. 2025 Jan;21(1):e14335. doi: 10.1002/alz.14335. Epub 2024 Dec 23.

Risks of Dementia Associated With Anticholinergic Medication Compared to Beta-3 Agonist Among Older Patients With Overactive Bladder in Japan: The LIFE Study

Okita Y, Shimomura Y, Komukai S, Zha L, Komatsu M, Kimura Y, Gon Y, Murata F, Maeda M, Kiyohara K, Kitamura T, Fukuda H.

Int J Geriatr Psychiatry. 2025 Jan;40(1):e70036. doi: 10.1002/gps.70036.

Long-Term Effect of Intensive vs Standard Blood Pressure Control on Mild Cognitive Impairment and Probable Dementia in SPRINT

Reboussin DM, Gaussoin SA, Pajewski NM, Jaeger BC, Sachs B, Rapp SR, Supiano MA, Cleveland ML, Hunter V, Demons JL, Ogrocki PK, Lerner AJ, Chelune GJ, Wadley VG, Scales ML, Woolard NF, Perdue LH, Call

Neurology. 2025 Feb 11;104(3):e213334. doi: 10.1212/WNL.0000000000213334. Epub 2025 Jan 16.

Association of Year-to-Year Lipid Variability With Risk of Cognitive Decline and Dementia in Community-Dwelling Older Adults

Zhou Z, Moran C, Murray AM, Zoungas S, Magnussen C, Chong TT, Shah RC, Sheets KM, Nelson M, Zhu C, Tonkin AM, Talic S, Ernst ME, Orchard SG, McNeil JJ, Wolfe R, Woods RL, Neumann JT, Qiu P, Ryan J.

Neurology. 2025 Feb 25;104(4):e210247. doi: 10.1212/WNL.0000000000210247. Epub 2025 Jan 29.

Neuroimaging Findings of Psychosis in Alzheimer's Disease: A Systematic Review

Nabizadeh F, Sheykhlou S, Mahmoodi S, Khalili E, Zafari R, Hosseini H.

Brain Behav. 2025 Jan;15(1):e70205. doi: 10.1002/brb3.70205.

Early detection and management of hearing loss to reduce dementia risk in older adults with mild cognitive impairment: findings from the treating auditory impairment and cognition trial (TACT)

Yu RC, Pavlou M, Schilder AGM, Bamiou DE, Lewis G, Lin FR, Livingston G, Proctor D, Omar R, Costafreda SG.

Age Ageing. 2025 Jan 6;54(1):afaf004. doi: 10.1093/ageing/afaf004.

Longitudinally persisting KCNA2-autoantibodies in mild amnestic dementia with Alzheimer´s pathology - Report and literature review

Hansen N, Teegen B, Hirschel S, Fox J, Fitzner D, Wiltfang J, Bartels C.

Behav Brain Res. 2025 Mar 28;482:115437. doi: 10.1016/j.bbr.2025.115437. Epub 2025 Jan 22.